585 related articles for article (PubMed ID: 33547249)
61. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
Renner H; Schöler HR; Bruder JM
Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
[TBL] [Abstract][Full Text] [Related]
62. Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery.
Silvestri A; Vicente F; Vicent MJ; Stechmann B; Fecke W
Drug Discov Today; 2021 Jun; 26(6):1369-1381. PubMed ID: 33677144
[TBL] [Abstract][Full Text] [Related]
63. Next-Generation Compound Delivery Platforms to Support Miniaturized Biology.
Bhatt S; Crimmin S; Gross J; Nixon E; Truong M; Weglos M; Kallal L
SLAS Technol; 2019 Jun; 24(3):245-255. PubMed ID: 30726680
[TBL] [Abstract][Full Text] [Related]
64. Organ-on-chip models: Implications in drug discovery and clinical applications.
Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
[TBL] [Abstract][Full Text] [Related]
65. A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons.
Sridharan B; Hubbs C; Llamosas N; Kilinc M; Singhera FU; Willems E; Piper DR; Scampavia L; Rumbaugh G; Spicer TP
Sci Rep; 2019 Jun; 9(1):9000. PubMed ID: 31227747
[TBL] [Abstract][Full Text] [Related]
66. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers.
Nguyen R; Bae SDW; Zhou G; Read SA; Ahlenstiel G; George J; Qiao L
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188350. PubMed ID: 32007597
[TBL] [Abstract][Full Text] [Related]
67. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
68. Cell death assays for neurodegenerative disease drug discovery.
Linsley JW; Reisine T; Finkbeiner S
Expert Opin Drug Discov; 2019 Sep; 14(9):901-913. PubMed ID: 31179783
[No Abstract] [Full Text] [Related]
69. Drug compound screening in single and integrated multi-organoid body-on-a-chip systems.
Skardal A; Aleman J; Forsythe S; Rajan S; Murphy S; Devarasetty M; Pourhabibi Zarandi N; Nzou G; Wicks R; Sadri-Ardekani H; Bishop C; Soker S; Hall A; Shupe T; Atala A
Biofabrication; 2020 Feb; 12(2):025017. PubMed ID: 32101533
[TBL] [Abstract][Full Text] [Related]
70. An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles.
Mishra I; Gupta K; Mishra R; Chaudhary K; Sharma V
Curr Pharm Biotechnol; 2024; 25(8):1000-1020. PubMed ID: 37807405
[TBL] [Abstract][Full Text] [Related]
71. Organoids: Past Learning and Future Directions.
O'Connell L; Winter DC
Stem Cells Dev; 2020 Mar; 29(5):281-289. PubMed ID: 31805828
[TBL] [Abstract][Full Text] [Related]
72. Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation.
Vandana JJ; Manrique C; Lacko LA; Chen S
Cell Stem Cell; 2023 May; 30(5):571-591. PubMed ID: 37146581
[TBL] [Abstract][Full Text] [Related]
73. 3D cell cultures toward quantitative high-throughput drug screening.
Wang Y; Jeon H
Trends Pharmacol Sci; 2022 Jul; 43(7):569-581. PubMed ID: 35504760
[TBL] [Abstract][Full Text] [Related]
74. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
75. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
Marotta N; Kim S; Krainc D
Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
[No Abstract] [Full Text] [Related]
76. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
[TBL] [Abstract][Full Text] [Related]
77. Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease.
Groveman BR; Ferreira NC; Foliaki ST; Walters RO; Winkler CW; Race B; Hughson AG; Zanusso G; Haigh CL
Sci Rep; 2021 Mar; 11(1):5165. PubMed ID: 33727594
[TBL] [Abstract][Full Text] [Related]
78. Advances in liver organoids: model systems for liver disease.
Lee J; Mun SJ; Shin Y; Lee S; Son MJ
Arch Pharm Res; 2022 Jun; 45(6):390-400. PubMed ID: 35661984
[TBL] [Abstract][Full Text] [Related]
79. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors.
Zhang YS; Aleman J; Shin SR; Kilic T; Kim D; Mousavi Shaegh SA; Massa S; Riahi R; Chae S; Hu N; Avci H; Zhang W; Silvestri A; Sanati Nezhad A; Manbohi A; De Ferrari F; Polini A; Calzone G; Shaikh N; Alerasool P; Budina E; Kang J; Bhise N; Ribas J; Pourmand A; Skardal A; Shupe T; Bishop CE; Dokmeci MR; Atala A; Khademhosseini A
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2293-E2302. PubMed ID: 28265064
[TBL] [Abstract][Full Text] [Related]
80. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
